FSH

FSH stands for Follicle Stimulating Hormone. It's a hormone made by your body that helps your ovaries and testes work properly. It helps prepare eggs or sperm for release.

Brand names:Follitropin
Medication

What people taking FSH report

Every report comes from a Lived member, sent anonymously.

Have you tried FSH for Female Infertility?

NameHow it went

About FSH

What It's For

FSH (follicle-stimulating hormone) is the hormone the pituitary gland uses to drive the growth of eggs in the ovaries and the production of sperm in the testes. As a medicine, it is injected during fertility treatment. Lab-made FSH is called follitropin: follitropin alfa is sold as Gonal-f (multi-dose vials) and Gonal-f RFF Redi-ject (a prefilled pen), and follitropin beta as Follistim AQ (a cartridge used in a pen). A related product, Menopur (menotropins), is purified from urine and contains both FSH and luteinizing hormone (LH) activity. In women, FSH is used in two main ways. For ovulation induction, it helps women who do not ovulate regularly mature and release an egg, aiming for one or a few mature follicles (the fluid-filled sacs in the ovary that each hold an egg). In IVF (in vitro fertilization) and related techniques, it is used to grow several follicles at once so that multiple eggs can be collected. It works only when the ovaries can still respond. It does not help when infertility comes from ovaries that have stopped working (primary ovarian failure), where the body's own FSH level is already high. In men, Gonal-f vials and Follistim AQ are approved to start sperm production in men with hypogonadotropic hypogonadism, a condition in which the pituitary gland does not send enough hormone signal to the testes. FSH is used together with hCG (human chorionic gonadotropin), another hormone injection, and it does not help when the testes themselves have failed. FSH treatment is prescribed and monitored by a fertility or hormone specialist.

How It Works

In a natural cycle, a rise in FSH recruits a group of follicles in the ovary, and usually only one matures and releases an egg. Injected FSH raises this signal on purpose. A modest, carefully adjusted dose can bring one or two follicles to maturity in someone who does not ovulate on their own. A higher dose overrides the body's usual selection so several follicles grow together, which is the goal in IVF. FSH grows follicles but does not release the egg. When ultrasound and blood tests show the follicles are ready, a separate trigger injection, such as hCG, completes egg maturation and sets off ovulation. In IVF, the eggs are retrieved about a day and a half after the trigger. In men, FSH acts on the cells in the testes that nurture developing sperm, while hCG restores testosterone; sperm production needs both signals.

Dosage & Administration

FSH is injected under the skin, usually in the abdomen, typically once a day during a stimulation cycle. Gonal-f RFF Redi-ject and Follistim AQ use pens with a dial that sets the dose. Gonal-f multi-dose vials are mixed with the supplied liquid and drawn into a syringe marked in units. The clinic teaches the technique, and most people inject at home. Doses are measured in international units (IU) and set individually, based on the diagnosis, test results and any response in a previous cycle. Ovulation induction starts low and rises slowly, with steps a week or more apart. IVF starts at a higher dose that is adjusted after the first several days according to monitoring. Products are not interchangeable unit for unit: the Follistim AQ pen, for example, delivers about 18% more drug than the older powder form given by syringe. Use only the product and dose prescribed, and do not change either without the clinic. For men, FSH is usually injected two or three times a week. It is added after several months of hCG alone has brought testosterone into the normal range, and the combination then continues for many months. If a dose is missed, do not double the next one; call the clinic for instructions. Storage rules differ between products (some are kept in the refrigerator), so follow the instructions for the one prescribed.

Side Effects

Headache, nausea, bloating and mild abdominal or pelvic discomfort are common during stimulation, as the ovaries enlarge. Soreness, redness or bruising at the injection site also happens, and ovarian cysts can form. Men may notice acne, pain at the injection site, tiredness or breast enlargement. The main serious risk for women is ovarian hyperstimulation syndrome (OHSS), in which the ovaries over-respond, swell and leak fluid into the abdomen and sometimes the chest. It usually develops after the trigger shot, peaks about 7 to 10 days after treatment, and is more severe and longer lasting if pregnancy occurs. Mild OHSS, with bloating, mild abdominal pain and some weight gain, is common and usually settles once a period starts; let the clinic know about it. Call the clinic right away for severe abdominal pain, weight gain of more than 2 pounds (1 kg) in a day, urinating much less than usual, nausea or vomiting that stops you keeping fluids down, dizziness, or shortness of breath. Severe OHSS can lead to blood clots and kidney problems and may need hospital care. Sudden, severe pain on one side of the pelvis can mean an enlarged ovary has twisted (ovarian torsion), which cuts off its blood supply and needs emergency care. Serious allergic reactions are rare; trouble breathing, swelling of the face or widespread hives after an injection need emergency care (call 911).

Interactions & Warnings

No formal drug interaction studies have been done with FSH. It is usually given as part of a planned combination with other fertility medicines, such as hCG and medicines that prevent early ovulation, so the fertility team should know about every other prescription, over-the-counter medicine and supplement you take. FSH is not used when the ovaries or testes have already failed, because FSH levels are already high and more will not help. It is also avoided in people with uncontrolled thyroid, adrenal or pituitary disease; tumors of the pituitary gland or hypothalamus; hormone-sensitive tumors of the reproductive organs; and, in women, unexplained vaginal bleeding or an ovarian cyst or enlargement that has not been explained. A previous allergic reaction to an FSH product rules out that product. Gonadotropin treatment raises the chance of twins or more, which brings higher risks during pregnancy and birth. Careful monitoring lowers this chance, and in IVF the number of embryos transferred matters most. Blood clots in veins or arteries are rare but serious, and are more likely in people with a personal or family history of clots, an inherited clotting disorder (thrombophilia) or severe obesity. Raise any of these before starting, since they change the balance of benefit and risk. Miscarriage is more common in pregnancies after gonadotropin treatment, although the medicine itself has not been shown to be the cause. Ectopic pregnancy (a pregnancy growing outside the uterus) can also occur after assisted reproduction, so an early ultrasound confirms where the pregnancy is. After a positive pregnancy test, pain on one side of the abdomen or pelvis, shoulder or neck pain, or pain with nausea and vomiting needs immediate medical attention. FSH is not used once a pregnancy has started.

What to Expect

A stimulation cycle takes time and planning. Expect frequent clinic visits for transvaginal ultrasound, which counts and measures the growing follicles, and blood tests for estradiol, a form of estrogen the follicles produce. Follicle size and rising estradiol show how the ovaries are responding and guide each dose change and the timing of the trigger shot. If too many follicles grow, the clinic may lower the dose, hold the trigger, cancel the cycle, or in IVF freeze the embryos and transfer one later. These steps exist to lower the risk of OHSS and of multiple pregnancy. Response varies from person to person and from cycle to cycle, and the response in one cycle shapes the dose in the next. People who are younger than 35, have polycystic ovary syndrome (PCOS), or grow an unusually large number of follicles have a higher risk of OHSS and need especially careful dosing. Treatment does not guarantee pregnancy, and more than one cycle may be needed. For men, building sperm production is slow. In the main Follistim AQ study, men who succeeded took a median of about five and a half months of FSH to reach a sperm count of at least 1 million per milliliter, and about 43% reached that level during the 48-week treatment period. Semen analysis and testosterone blood tests track progress.

Questions to Ask Your Doctor

  1. 1.Which FSH product and starting dose do you recommend for me, and why?
  2. 2.How often will I need ultrasounds and blood tests, and how will the results change the plan?
  3. 3.What is my personal risk of OHSS and of twins, and what would we do if I over-respond?
  4. 4.Which symptoms should make me call the clinic, and how do I reach someone after hours?
  5. 5.What are my realistic chances of success with this approach, and how many cycles would we try before changing course?

Last reviewed • Oct 2026

Educational content, not medical advice.